Recent developments in immunotherapy of acute myeloid leukemia

por Lichtenegger, Felix S., Krupka, Christina, Haubner, Sascha, Köhnke, Thomas, Subklewe, Marion
Publicado 2017

Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens

por Hänel, Gerulf, Angerer, Caroline, Petry, Katja, Lichtenegger, Felix S., Subklewe, Marion
Publicado 2021

CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells

por Lichtenegger, Felix S., Mueller, Katharina, Otte, Bettina, Beck, Barbara, Hiddemann, Wolfgang, Schendel, Dolores J., Subklewe, Marion
Publicado 2012

Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission

por Beck, Barbara, Dörfel, Daniela, Lichtenegger, Felix S, Geiger, Christiane, Lindner, Lysann, Merk, Martina, Schendel, Dolores J, Subklewe, Marion
Publicado 2011

T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment

por Schnorfeil, Frauke M., Lichtenegger, Felix S., Emmerig, Katharina, Schlueter, Miriam, Neitz, Julia S., Draenert, Rika, Hiddemann, Wolfgang, Subklewe, Marion
Publicado 2015

Cellular Uptake of Tile-Assembled DNA Nanotubes

por Kocabey, Samet, Meinl, Hanna, MacPherson, Iain S., Cassinelli, Valentina, Manetto, Antonio, Rothenfusser, Simon, Liedl, Tim, Lichtenegger, Felix S.
Publicado 2014

Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells

por Lichtenegger, Felix S., Rothe, Maurine, Schnorfeil, Frauke M., Deiser, Katrin, Krupka, Christina, Augsberger, Christian, Schlüter, Miriam, Neitz, Julia, Subklewe, Marion
Publicado 2018

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia

por Schnorfeil, Frauke, Lichtenegger, Felix, Geiger, Christiane, Köhnke, Thomas, Bücklein, Veit, Altmann, Torben, Wagner, Beate, Henschler, Reinhard, Bigalke, Iris, Kvalheim, Gunnar, Hiddemann, Wolfgang, Schendel, Dolores, Subklewe, Marion
Publicado 2014

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

por Van Acker, Heleen H., Versteven, Maarten, Lichtenegger, Felix S., Roex, Gils, Campillo-Davo, Diana, Lion, Eva, Subklewe, Marion, Van Tendeloo, Viggo F., Berneman, Zwi N., Anguille, Sébastien
Publicado 2019

Targeting CD157 in AML using a novel, Fc-engineered antibody construct

por Krupka, Christina, Lichtenegger, Felix S., Köhnke, Thomas, Bögeholz, Jan, Bücklein, Veit, Roiss, Michael, Altmann, Torben, Do, To Uyen, Dusek, Rachel, Wilson, Keith, Bisht, Arnima, Terrett, Jon, Aud, Dee, Pombo-Villar, Esteban, Rohlff, Christian, Hiddemann, Wolfgang, Subklewe, Marion
Publicado 2017

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade

por Ruzicka, Michael, Koenig, Lars M., Formisano, Simone, Boehmer, Daniel F. R., Vick, Binje, Heuer, Eva-M., Meinl, Hanna, Kocheise, Lorenz, Zeitlhöfler, Marcus, Ahlfeld, Julia, Kobold, Sebastian, Endres, Stefan, Subklewe, Marion, Duewell, Peter, Schnurr, Max, Jeremias, Irmela, Lichtenegger, Felix S., Rothenfusser, Simon
Publicado 2019

Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

por Lichtenegger, Felix S, Schnorfeil, Frauke M, Rothe, Maurine, Deiser, Katrin, Altmann, Torben, Bücklein, Veit L, Köhnke, Thomas, Augsberger, Christian, Konstandin, Nikola P, Spiekermann, Karsten, Moosmann, Andreas, Boehm, Stephan, Boxberg, Melanie, Heemskerk, Mirjam HM, Goerlich, Dennis, Wittmann, Georg, Wagner, Beate, Hiddemann, Wolfgang, Schendel, Dolores J, Kvalheim, Gunnar, Bigalke, Iris, Subklewe, Marion
Publicado 2020